ArticlesDroplet Digital PCR (ddPCR)Drug Discovery and Development

CDMOs Drive Cell and Gene Therapy from Behind the Scenes

As more of the cell and gene therapies revolutionizing healthcare are approved for use, innovator companies usually get the credit. But many therapies would never make it to market without the expertise and capabilities of contract development and manufacturing organizations (CDMOs) operating behind the scenes. Learn more about how CDMOs enable new cell and gene therapies to come to market, and how Droplet Digital PCR can help.
READ MORE →
ArticlesDroplet Digital PCR (ddPCR)Drug Discovery and Development

The Role of ddPCR in Developing Safe and Effective AAV-Based Gene Therapies

Developing adeno-associated virus (AAV)-mediated gene therapies requires accurate and precise quality control. Read how Droplet Digital PCR technology provides the sensitivity needed to assess the potential safety and effectiveness of these treatments.
READ MORE →
ArticlesDroplet Digital PCR (ddPCR)Drug Discovery and Development

Top 5 Challenges Faced by AAV Developers Today

Adeno-associated viruses (AAVs) are some of the most commonly used viral vectors for gene therapy, supporting approximately 250 clinical trials to date. However, the manufacturing processes are challenging to scale. Read about five key issues that gene therapy manufacturers who use AAVs need to look out for.
READ MORE →
Droplet Digital PCR (ddPCR)Past WebinarsWebinars

Expert Coffee Chats: Coffee Chat #4 – Droplet Digital PCR in Cell and Gene Therapy

Presented by: Matthew L. Turner, PhD, Field Application Scientist – ddPCR, NGC and qPCR, Tara Ellison, PhD, Senior Field Application Scientist

Date: June 17, 2020
Time: 9 AM, U.S. Pacific time

  • Robust methodology for viral titer using ddPCR
  • Precise copy number determination & improved confidence in acceptance criteria
  • Enhance your throughput and minimize hands-on time
  • Learn how ddPCR is used in other key applications
READ MORE →